米国における鎮痛薬市場

The mature, $2.2 billion internal analgesics market has declined 2.4% between 1998 and 2003, which translates into a decline of 13.5% at constant 2003 prices. While internal analgesics are likely to be found in almost every medicine cabinet in the country, overall sales have slipped in all categories. The growth of store brand is especially obvious in single-ingredient formulations that have been on the market for years such as acetaminophen (branded Tylenol) and ibuprofen (branded Advil, Motrin), but store brands are also keeping pace with the latest branded entrants such as naproxen (branded Aleve). While low dose aspirin therapy for heart health may push sales of acetylsalicylic acid (aspirin or ASA), there is also press being devoted to the over-use of analgesics. In 2004, the FDA focused efforts on its campaign to educate consumers about the risks associated with "over-use" of common pain relievers, which should make consumers more cautious about following proper analgesic dosage to relieve arthritis or inflammation. New research into the possible uses of analgesics as preventative therapies for Alzheimer's disease, stroke, breast cancer, and other health problems could help the market.

Of interest to consumers are a number of new products and formulations. "Targeted" analgesics, which are designed to treat a specific type of pain (e.g. Tylenol Arthritis, Advil Migraine) leverage new rulings from the FDA that allow additional ingredients and their benefits to be promoted on package labels. Hygroscopic (quick-release) products such as Excedrin QuickTabs dissolve in the mouth and do not require water, making analgesics portable and easier to use. Products formulated especially for infants and toddlers (Infant Motrin, children's chewable Tylenol) have also gained in popularity as more parents look for products that are "kid friendly" and effective.

This report examines the theory that over-the-counter internal analgesic sales will face future sales challenges. To counteract projected declines, analgesic manufacturers need a thorough understanding of consumer purchasing habits and attitudes. For example, alternative products and external analgesics are areas of increased interest among consumers. Manufacturers who are adjusting marketing strategies according to consumer opinion are the most likely to adapt to the changing analgesics market.

For the purposes of this report, the analgesics market is defined as including all oral analgesics, which are available over the counter without a prescription. They contain one or more of the following ingredients:

• Acetaminophen (APAP)
• Aspirin (ASA)
• Ibuprofen
• Ketoprofen
• Naproxen sodium

Excluded from this report are the following products:

• Antihistamines
• Decongestants
• Cough remedies
• Topical or external analgesics, such as liniments or pain-relief gels, creams or sprays
• Sleep aids
• Alertness aids

Contents

INTRODUCTION AND ABBREVIATIONS

• Introduction
• Other Relevant Reports
• Definition
• Abbreviations Terms
• Abbreviations
• Terms

EXECUTIVE SUMMARY

• Baby boomers and seniors are major drivers for analgesics market
• Babies and toddler formulations grow sales
• Specific symptom pain relief could generate new customers
• OTC vs. prescription drugs
• Prevention may be the best medicine
• Targeting a specific type of pain
• Big gains in external analgesics market
• Interest in alternative products
• A $2.2 billion market
• Delivery systems distinguish segments
• Four big players and store brands account for most sales
• McNeil is biggest spender on media
• Drug stores edge out supermarkets for sales in 2003
• Respondents are more likely to use extra strength products
• Two thirds of respondents take pain killers for headaches
• Drug stores and supermarkets favorite purchase sites
• Future trends
• Analgesics forecast to decline

MARKET DRIVERS

• Aging population boosts market
• Figure 1: U.S. population projections, 1998, 2003 and 2008
• More products for children
• Incidence of specific ailments
• Figure 2: Prevalence of specific conditions/ailments among population aged 18 and older, by percent of population, 2001
• OTC and prescription drug use
• Figure 3: Usage of OTC vs. prescription drugs for specific ailments, January-September 2003
• Prophylactic uses of analgesics
• Analgesics targeting specific pain symptoms
• Competition from other products
• External analgesics
• Alternative medicines

MARKET SIZE TRENDS

• Figure 4: Total U.S. retail sales of analgesic products, at current and constant prices, 1998-2003*
• Graph 1: Total U.S. retail sales of internal analgesic products, at current and constant prices, 1998-2003*

MARKET SEGMENTATION

• Figure 5: Sales of analgesics, segmented by delivery system, 2001 and 2003*
• Analgesic tablets
• Figure 6: Sales of analgesic tablets, at current and constant prices, 1998-2003*
• Analgesic liquids
• Figure 7: Sales of analgesic liquids, at current and constant prices, 1998-2003*

SUPPLY STRUCTURE

COMPANIES AND BRANDS

• Figure 8: Manufacturer sales of internal analgesic products in the U.S., 2001 2003*
• Analgesic tablets
• Figure 9: Manufacturer brand sales of internal analgesic tablets in the U.S., 2001 and 2003*
• Analgesic liquids
• Figure 10: Manufacturer brand sales of internal analgesic liquids in the U.S., 2001 2003*
• Profiles of Major Manufacturers
• McNeil Consumer Products (Johnson Johnson)
• Wyeth
• Bayer Consumer Health Division International
• Bristol Myers-Squibb

ADVERTISING PROMOTION

• McNeil Consumer Products
• Bayer Consumer Health Division International
• Bristol Myers-Squibb
• Wyeth

RETAIL DISTRIBUTION

• Introduction
• Figure 11: U.S. retail sales of internal analgesic products, by channel, 2001 and 2003*
• Drug stores
• Figure 12: U.S. drug store sales of internal analgesics, at current and constant prices, 1998-2003
• Drug store operating data
• Figure 13: Top drug store operating statistics, latest fiscal year-end
• Figure 14: Percentage change from latest fiscal year-end versus year prior
• Supermarkets
• Figure 15: U.S. supermarket sales of internal analgesics, at current and constant prices, 1998-2003
• Supermarket operating data
• Figure 16: Top supermarket operating statistics, latest fiscal year-end
• Figure 17: Percentage change from latest fiscal year-end versus year prior

THE CONSUMER

• Introduction
• Usage of analgesics
• Figure 18: Usage of OTC analgesics, January 2003-September 2003
• Figure 19: Usage of OTC analgesics, by gender, January 2003-September 2003
• Figure 20: Usage of OTC analgesics, by age, January 2003-September 2003
• Figure 21: Usage of OTC analgesics, by race/ethnicity, January 2003-September 2003
• Types of analgesics used
• Figure 22: Types of analgesics used, January 2003-September 2003
• Figure 23: Types of analgesics used, by age, January 2003-September 2003
• Figure 24: Types of analgesics used, by race/ethnicity, January 2003-September 2003
• Forms of analgesics used
• Figure 25: Forms of analgesics used, January 2003-September 2003
• Figure 26: Forms of analgesics used, by age, January 2003-September 2003
• Figure 27: Forms of analgesics used, by race/ethnicity, January 2003-September 2003
• Reasons for using OTC analgesics
• Figure 28: Ailments for which OTC analgesics are used, January 2003-September 2003
• Figure 29: Ailments for which OTC analgesics are used, by gender, January 2003-September 2003
• Figure 30: Ailments for which OTC analgesics are used, by age, January 2003-September 2003
• Figure 31: Ailments for which OTC analgesics are used, by race/ethnicity, January 2003-September 2003
• Purchase venues for OTC analgesics
• Figure 32: Purchase venues for OTC pain relievers, May 2004
• Figure 33: Purchase venues for OTC pain relievers, by age, May 2004
• Figure 34: Purchase venues for OTC pain relievers, by household income, November 2000
• Figure 35: Purchase venues for OTC pain relievers, by race/ethnicity, November 2000
• Interest in new forms of analgesics
• Figure 36: Interest in new forms of pain relievers, May 2004
• Figure 37: Interest in new forms of pain relievers, by age, May 2004
• Figure 38: Interest in new forms of pain relievers, by household income, May 2004
• Attitudes and opinions concerning analgesics
• Figure 39: Attitudes towards analgesics, May 2004
• Figure 40: Attitudes towards analgesics, by age, May 2004
• Analgesics and health issues
• Figure 41: Knowledge of potential risk of mixing acetominophen and alcohol, May 2004
• Figure 42: Knowledge of potential risk of mixing acetominophen and alcohol, by age, May 2004
• Opinions concerning OTC and prescription medications
• Figure 43: Attitudes towards OTC vs. prescription medications, January 2003-September 2003
• Figure 44: Attitudes towards OTC vs. prescription medications, by age, January 2003-September 2003
• Figure 45: Attitudes towards OTC vs. prescription medications, by race/ethnicity, January 2003-September 2003
• Summary

FUTURE FORECAST

FUTURE TRENDS

• Aging population will help drive sales
• Interest in children's products will also continue
• Specific ailments require specific treatments
• Prophylactic usage of analgesics may drive market
• Competition

MARKET FORECAST

• Analgesics
• Figure 46: Forecast of total U.S. retail sales of analgesic products, at current and constant prices, 2003-2008
Graph 2: Sales of analgesics at current prices, 1998-2008
• Analgesic Tablets
• Figure 47: Forecast of U.S. sales of analgesic tablets, at current and constant prices, 2003-2008
• Analgesic Liquids
• Figure 48: Forecast of U.S. sales of analgesic liquids, at current and constant prices, 2003-2008
• Forecast Factors

APPENDIX: TRADE ASSOCIATIONS

APPENDIX: NEW PRODUCT BRIEFS

• Chattem: Pamprin All Day Maximum Strength Pain Reliever
• McNeil Consumer Products: Tylenol Extra Strength Cool Caplets
• McNeil Consumer Products: Tylenol Arthritis Pain Extended Pain Relief
• Bayer: Bayer Children's Genuine Aspirin Chewable Tablets
• Bayer: Bayer Safety Coated Aspirin
• Bayer: Bayer Mint Flavor Chewable Aspirin
• Bayer: Bayer Women's Aspirin
• Bristol Myers-Squibb: Excedrin Tension Headache

APPENDIX: RESEARCH METHODOLOGY

• Consumer Research
• Sampling Weighting
• Presentation Definition
• Further Analysis
• Trade Research
• Informal trade research
• Formal trade research
• Desk Internet Research
• Sources
• Definitions
• Forecasts

APPENDIX: WHAT IS MINTEL?

• Mintel Publications
• Mintel Services
• Product retrieval
• Retail audits
• Tailored research
• Global New Products Database
• Research Support/Consultancy/MIC
• The Mintel Information Centre (MiC)
• PR Research